Bacteriophages for managing Shigella in various clinical and non-clinical settings.

Bacteriophage Pub Date : 2013-01-01 Epub Date: 2013-05-21 DOI:10.4161/bact.25098
Lawrence D Goodridge
{"title":"Bacteriophages for managing Shigella in various clinical and non-clinical settings.","authors":"Lawrence D Goodridge","doi":"10.4161/bact.25098","DOIUrl":null,"url":null,"abstract":"<p><p>The control of shigellosis in humans enjoys a prominent position in the history of bacteriophage therapy. d'Herelle first demonstrated the efficacy of phage therapy by curing 4 patients of shigellosis, and several subsequent studies confirmed the ability of phages to reduce <i>Shigella</i> based infection. <i>Shigella</i> spp continue to cause millions of illnesses and deaths each year and the use of phages to control the disease in humans and the spread of the bacteria within food and water could point the way forward to the effective management of an infectious disease with global influence.</p>","PeriodicalId":8686,"journal":{"name":"Bacteriophage","volume":"3 1","pages":"e25098"},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/bact.25098","citationCount":"24","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bacteriophage","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4161/bact.25098","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2013/5/21 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 24

Abstract

The control of shigellosis in humans enjoys a prominent position in the history of bacteriophage therapy. d'Herelle first demonstrated the efficacy of phage therapy by curing 4 patients of shigellosis, and several subsequent studies confirmed the ability of phages to reduce Shigella based infection. Shigella spp continue to cause millions of illnesses and deaths each year and the use of phages to control the disease in humans and the spread of the bacteria within food and water could point the way forward to the effective management of an infectious disease with global influence.

Abstract Image

Abstract Image

Abstract Image

在各种临床和非临床环境中用于控制志贺氏菌的噬菌体。
人类志贺氏菌病的控制在噬菌体治疗史上占有重要地位。d'Herelle首先通过治愈4例志贺氏菌病患者证明了噬菌体治疗的有效性,随后的几项研究证实了噬菌体减少志贺氏菌感染的能力。志贺氏菌每年继续造成数百万人患病和死亡,利用噬菌体控制人类患病和细菌在食物和水中的传播,可能为有效管理具有全球影响的传染病指明方向。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信